An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma

We evaluated the usefulness of an oncolytic virus (Suratadenoturev; OBP-301) against radioresistant oral squamous cell carcinoma. We confirmed the expression of human telomerase reverse transcriptase and the coxsackievirus and adenovirus receptor in cell lines. Also, we examined the potential presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gohara, Shunsuke, Shinohara, Kosuke, Yoshida, Ryoji, Kariya, Ryusho, Tazawa, Hiroshi, Hashimoto, Masashi, Inoue, Junki, Kubo, Ryuta, Nakashima, Hikaru, Arita, Hidetaka, Kawaguchi, Sho, Yamana, Keisuke, Nagao, Yuka, Iwamoto, Asuka, Sakata, Junki, Matsuoka, Yuichiro, Takeshita, Hisashi, Hirayama, Masatoshi, Kawahara, Kenta, Nagata, Masashi, Hirosue, Akiyuki, Kuwahara, Yoshikazu, Fukumoto, Manabu, Okada, Seiji, Urata, Yasuo, Fujiwara, Toshiyoshi, Nakayama, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619351/
https://www.ncbi.nlm.nih.gov/pubmed/36381653
http://dx.doi.org/10.1016/j.omto.2022.10.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619351/
https://www.ncbi.nlm.nih.gov/pubmed/36381653
http://dx.doi.org/10.1016/j.omto.2022.10.001

Ejemplares similares